Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Donald

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|January 15, 2013
Early bactericidal activity of new drug regimens for tuberculosis - Authors' replyAndreas H Diacon, Peter R Donald, Carl M Mendel
Personalized Medicine|May 24, 2018
NAT2 polymorphisms and their influence on the pharmacology and toxicity of isoniazid in TB patientsCedric J Werely, Peter R Donald, Paul D van Helden
The Pediatric Infectious Disease Journal|November 1, 2014
In reply: Acquired drug-resistance because of pharmacokinetic variability in a young child with tuberculosisAnthony J Garcia-Prats, Peter R Donald, H Simon Schaaf
Swiss Medical Weekly|August 24, 2012
From magic mountain to table mountainAndreas H Diacon, Florian von Groote-Bidlingmaier, Peter R Donald
Journal of Tropical Pediatrics|December 16, 2011
Multidrug-resistant tuberculosis of the spine in children--characteristics from a high burden settingJames A Seddon, Peter R Donald, Gert J Vlok, et al.
The Journal of Infection|February 9, 2006
A critical look at the diagnostic value of culture-confirmation in childhood tuberculosisArnold L Engelbrecht, Ben J Marais, Peter R Donald, et al.
Acta Neuropathologica|December 16, 2006
Tuberculous encephalopathy: a reappraisalG Alistair Lammie, Richard H Hewlett, Johan F Schoeman, et al.
The Journal of Infection|July 29, 2009
Tuberculous cerebrovascular disease: a reviewG Alistair Lammie, Richard H Hewlett, Johan F Schoeman, et al.
Clinical Drug Investigation|February 4, 2014
Dose regimen of para-aminosalicylic acid gastro-resistant formulation (PAS-GR) in multidrug-resistant tuberculosisYves Kibleur, Hervé Brochart, Hendrik S Schaaf, et al.
Medical Microbiology and Immunology|August 2, 2024
Carl Flügge, one of the last holistic hygienists and discoverer of droplet transmission of infectious diseasesPeter R Donald, Stefan H E Kaufmann, Dagmar Schaub, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|January 15, 2013
Early bactericidal activity of new drug regimens for tuberculosis - Authors' replyAndreas H Diacon, Peter R Donald, Carl M Mendel
Personalized Medicine|May 24, 2018
NAT2 polymorphisms and their influence on the pharmacology and toxicity of isoniazid in TB patientsCedric J Werely, Peter R Donald, Paul D van Helden
The Pediatric Infectious Disease Journal|November 1, 2014
In reply: Acquired drug-resistance because of pharmacokinetic variability in a young child with tuberculosisAnthony J Garcia-Prats, Peter R Donald, H Simon Schaaf
Swiss Medical Weekly|August 24, 2012
From magic mountain to table mountainAndreas H Diacon, Florian von Groote-Bidlingmaier, Peter R Donald
Journal of Tropical Pediatrics|December 16, 2011
Multidrug-resistant tuberculosis of the spine in children--characteristics from a high burden settingJames A Seddon, Peter R Donald, Gert J Vlok, et al.
The Journal of Infection|February 9, 2006
A critical look at the diagnostic value of culture-confirmation in childhood tuberculosisArnold L Engelbrecht, Ben J Marais, Peter R Donald, et al.
Acta Neuropathologica|December 16, 2006
Tuberculous encephalopathy: a reappraisalG Alistair Lammie, Richard H Hewlett, Johan F Schoeman, et al.
The Journal of Infection|July 29, 2009
Tuberculous cerebrovascular disease: a reviewG Alistair Lammie, Richard H Hewlett, Johan F Schoeman, et al.
Clinical Drug Investigation|February 4, 2014
Dose regimen of para-aminosalicylic acid gastro-resistant formulation (PAS-GR) in multidrug-resistant tuberculosisYves Kibleur, Hervé Brochart, Hendrik S Schaaf, et al.
Medical Microbiology and Immunology|August 2, 2024
Carl Flügge, one of the last holistic hygienists and discoverer of droplet transmission of infectious diseasesPeter R Donald, Stefan H E Kaufmann, Dagmar Schaub, et al.
Pageof 9